Fludarabine and Rituximab With or Without Pixantrone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin Lymphoma
CTI BioPharma
CTI BioPharma
Jonsson Comprehensive Cancer Center
M.D. Anderson Cancer Center
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
Massachusetts General Hospital
M.D. Anderson Cancer Center
University of California, San Francisco
National Institutes of Health Clinical Center (CC)